Temple University Hospital – Main Campus, Temple Health – Chestnut Hill Hospital, and TUH – Jeanes Campus have been recognized by the American Heart Association for their efforts in providing quality stroke care.
The awards are part of the Get With The Guidelines program. TUH – Main Campus received the Stroke Gold Plus with Target: Stroke℠ Honor Roll Elite Plus and Target: Type 2 Diabetes Honor Roll awards. Temple Health – Chestnut Hill Hospital was awarded Stroke Gold Plus with Target: Stroke Honor Roll and Target: Type 2 Diabetes Honor Roll. TUH – Jeanes Campus earned Stroke Gold Plus with Target: Type 2 Diabetes Honor Roll.
These recognitions highlight adherence to nationally recognized, research-based guidelines for treating stroke patients. The Gold Plus award acknowledges hospitals that consistently deliver recommended treatment, which can lead to more lives saved and less disability among patients.
Hospitals receiving the Target: Stroke Honor Roll Elite Plus or Target: Stroke Honor Roll must meet criteria that reduce the time between a patient’s arrival at the hospital and administration of thrombolytic therapy, a critical intervention for eligible stroke patients.
The Target: Type 2 Diabetes Honor Roll award is given to hospitals that ensure stroke patients with Type 2 diabetes receive up-to-date care based on current evidence. This group of patients may be at higher risk for complications from strokes.
“Temple Health is committed to providing safe, high-quality care to our patients using the latest research- and evidence-based treatment guidelines, and this recognition is further proof of the success of those efforts,” said Abhi Rastogi, MBA, MIS, Executive Vice President of Temple Health and President and CEO of Temple University Hospital Inc. “The end goal is to ensure more people can experience longer, healthier lives.”
According to health experts, stroke remains one of the leading causes of death in the United States as well as a major cause of disability. A stroke occurs when blood flow to part of the brain is blocked or interrupted by a clot or burst vessel. This can result in loss of oxygen supply to brain cells, causing them to die. Quick detection and treatment are crucial for improving survival rates and reducing long-term effects.
